Health & Fitness

According to FutureWise analysis the Microservices in Healthcare Market in 2026 is US$ 0.52 billion, and is expected to reach US$ 1.75 billion by 2036 at a CAGR of 12.90%. The growth is fueled by the rising use of cloud computing, digital health platforms, and modular IT in healthcare. Microservices allow for better scalability, quicker app development, and easier integration with EHRs, telehealth, and AI solutions. Additionally, a focus on interoperability, data security, and agile IT modernization is driving market expansion. Microservices architecture offers a framework for applications, particularly system software, to operate with functional modules that emphasize efficiency and accuracy, along with robust interfacing capabilities. This architecture enables the integration of various services and techniques into APIs (Application Programming Interfaces), allowing for greater flexibility and functionality. In the healthcare sector, microservices play a crucial role in optimizing ... Continue reading →

According to FutureWise analysis the market for Microsurgery in 2026 is US$ 2.68 billion, and is expected to reach US$ 4.10 billion by 2036 at a CAGR of 4.34%. Rising demand for minimally invasive surgeries in neurology, ophthalmology, plastic surgery, and orthopedics is driving growth. Technological advancements in surgical microscopes, microsurgical instruments, and robotic systems enhance precision and outcomes. The increasing prevalence of trauma cases and chronic conditions also contributes to market expansion. Microsurgery is a specialized surgical discipline focused on performing intricate procedures on very small anatomical structures. Utilizing advanced magnification, precision instruments, and refined techniques, microsurgeons can repair blood vessels, nerves, and tissues that might be difficult to treat through conventional surgical methods. It has become an essential aspect of modern medicine, significantly enhancing both functional and aesthetic outcomes across various ... Continue reading →

According to FutureWise analysis the market for Microtome in 2026 is US$ 0.49 billion, and is expected to reach US$ 0.86 billion by 2036 at a CAGR of 5.79%. The growth in histopathology and anatomical pathology services is fueled by rising demand for disease diagnosis and research. Innovations in microtome design, including automation and improved safety features, are enhancing sectioning precision and laboratory efficiency. Additionally, increasing cancer rates and expanding clinical laboratory infrastructure are contributing to market growth. A microtome is an essential piece of laboratory equipment designed for sample preparation, allowing researchers to cut extremely thin slices of various materials for microscopic analysis. Historically, samples were prepared manually with blades and razors, which limited the thickness of the slices. However, the advent of microtomes has revolutionized this process, enabling the production of slices as thin as 10 nanometers, suitable for ... Continue reading →

According to FutureWise analysis the market for Military Wearable Medical Device in 2026 is US$ 13.05 billion, and is expected to reach US$ 72.39 billion by 2036 at a CAGR of 18.69%. Rapid growth in soldier health monitoring and battlefield injury management is fueled by advancements in sensor technology, AI analytics, and durable wearables. These innovations enhance situational awareness and medical decision-making in combat. Increased defense spending and the uptake of connected health solutions are also driving market expansion. Wearable technology is rapidly evolving into a cornerstone of modern biomedical advancements, paving the way for innovative approaches to healthcare management. These devices provide unparalleled convenience and user-friendly interfaces, empowering patients with chronic diseases to actively monitor and manage their health conditions. By facilitating continuous health tracking, wearables significantly aid in the early detection of potential complications, ... Continue reading →

According to FutureWise analysis the market for minimally invasive glaucoma surgery (migs) devices in 2026 is US$ 0.76 billion, and is expected to reach US$ 1.20 billion by 2036 at a CAGR of 4.67%. Growth in the market is fueled by the rising prevalence of glaucoma, a shift toward safer, quicker surgical options, and advancements in micro-stent technologies. MIGS devices provide quicker recovery, fewer complications, and are increasingly used alongside cataract surgeries, gaining wider clinical acceptance globally. Minimally invasive glaucoma surgery (MIGS) devices are becoming an important option for treating glaucoma patients due to their ab interno technique, which helps avoid both medication reliance and conjunctival invasion. These devices, including stents, shunts, and micro implants, are primarily used for patients with mild to moderate glaucoma. Over time, there has been a notable shift in preference towards MIGS devices compared to traditional glaucoma surgical options, ... Continue reading →

According to FutureWise analysis the market for Minimally Invasive Neurosurgery Device in 2026 is US$ 3.26 billion, and is expected to reach US$ 6.09 billion by 2036 at a CAGR of 6.45%. Market growth is driven by the rising use of minimally invasive techniques in brain and spine surgeries, advancements in neuronavigation and endoscopic systems, and the demand for procedures that lessen surgical trauma. Additionally, the increasing prevalence of neurological disorders and the expansion of specialized neurosurgical centers are contributing to this growth. Minimally Invasive Neurosurgery Devices mark a notable progression in the neurosurgery field, allowing for the diagnosis and treatment of intricate neurological conditions with increased precision while reducing trauma to adjacent tissues. In contrast to traditional open neurosurgical methods, minimally invasive techniques utilize specialized instruments, endoscopes, image-guided systems, and advanced surgical tools, which facilitate ... Continue reading →

According to FutureWise analysis the market for minimally invasive surgery devices in 2026 is US$ 37.31 billion, and is expected to reach US$ 62.15 billion by 2036 at a CAGR of 5.24%. The growth is driven by the rising adoption of minimally invasive procedures in various specialties like general surgery, orthopedics, cardiology, and gynecology, thanks to benefits such as reduced pain and faster recovery. Technological advancements in endoscopic instruments, robotic systems, and imaging, along with the demand for outpatient and cost-effective solutions, are also fueling market expansion. Minimally invasive surgery (MIS) devices have greatly transformed surgical practices by allowing complex procedures to be conducted through smaller incisions. This approach enhances precision and contributes to better patient outcomes. These devices aim to minimize surgical trauma while achieving, or even surpassing, the effectiveness of traditional open surgeries. By reducing tissue damage and blood ... Continue reading →

According to FutureWise analysis, the Mid-Revenue Cycle Management or Clinical Documentation Improvement market in 2026 is US$4.52 billion, and is expected to reach US$7.83 billion by 2036 at a CAGR of 5.65%.  The Mid-Revenue Cycle Management and Clinical Documentation Improvement (CDI) market is currently experiencing significant growth, largely due to an increased focus on accurate clinical documentation and the urgent need to reduce claim denials. Healthcare providers are investing heavily in CDI solutions to enhance coding accuracy and ensure that they receive the reimbursements they are entitled to. As the healthcare industry transitions towards value-based care models, the importance of comprehensive documentation practices becomes even more critical. North America is at the forefront of this trend, driven by stringent healthcare compliance regulations and the widespread implementation of electronic health records (EHRs), which are transforming the documentation landscape. ... Continue reading →

According to FutureWise analysis the market for minimally invasive surgical instruments in 2026 is US$ 29.48 billion, and is expected to reach US$ 67.51 billion by 2036 at a CAGR of 8.64%. Strong growth in the market is driven by the increasing adoption of laparoscopic and endoscopic procedures in hospitals and surgical centers, thanks to benefits like reduced surgical trauma and quicker recovery. Innovations in handheld instruments and energy-based devices, along with a rising demand for precision in complex procedures, are further propelling market expansion. Minimally invasive surgical instruments, such as electrosurgical systems, robot-assisted surgical systems, and various surgical equipment, play a crucial role in modern surgical practices. Minimally invasive surgery (MIS) is defined as surgical treatment performed through small incisions, rather than the larger incisions associated with traditional open surgery. This approach offers several benefits, including faster recovery ... Continue reading →

According to FutureWise analysis the market for Minimally Invasive Thoracic Surgery in 2026 is US$ 5.04 billion, and is expected to reach US$ 7.57 billion by 2036 at a CAGR of 4.15%. Market growth is fueled by the rising use of video-assisted and robotic-assisted thoracic procedures for lung cancer and other chest conditions. Advantages like smaller incisions, less postoperative pain, shorter hospital stays, and better clinical outcomes are leading to greater acceptance among surgeons and patients in advanced healthcare settings. Minimally Invasive Thoracic Surgery (MITS) has become a transformative approach for diagnosing and treating diseases affecting the chest, including conditions related to the lungs, esophagus, pleura, and mediastinum. Unlike traditional open thoracic surgery, which often requires large incisions and the spreading of ribs, minimally invasive techniques use small incisions, specialized instruments, and advanced visualization systems to access thoracic structures ... Continue reading →